The US Fructosamine Reagents Market is experiencing steady growth, driven by the rising prevalence of diabetes, increasing demand for advanced glycemic monitoring, and widespread adoption of automated clinical chemistry analyzers. The country's well-established healthcare infrastructure, strong diagnostic laboratory network, and growing emphasis on personalized diabetes management continue to...